Coca-Cola Consolidated, Inc. Common Stock
COKE
$0.00
-3.14%
Coca-Cola Consolidated, Inc. is a major distributor, marketer, and manufacturer of non-alcoholic beverages. It is a key bottler and distributor for The Coca-Cola Company, leveraging a strong regional footprint and extensive distribution network.
COKE
Coca-Cola Consolidated, Inc. Common Stock
$0.00
Investment Opinion: Should I buy COKE Today?
Based on a synthesis of the available data, the objective assessment for COKE is a Hold. The company's strong operational metrics, growth trajectory, and attractive forward earnings multiple are positive. However, these are counterbalanced by significant red flags in its balance sheet structure and the stock's recent volatility following a substantial rally. Investors should await clarification on the capital structure issues or a more attractive entry point before establishing a new position.
Sign up to view all
COKE 12-Month Price Forecast
The analysis yields a neutral stance with medium confidence. The company's underlying business is healthy, but severe distortions in its reported financial position create too much uncertainty to be bullish. The recent price decline may offer an entry, but only for investors comfortable with the structural risks.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Coca-Cola Consolidated, Inc. Common Stock's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
1 analysts
Implied Upside
—
vs. current price
Analyst Count
1
covering this stock
Price Range
$0 - $0
Analyst target range
No sufficient analyst coverage available. The provided data indicates only one analyst, with no specific target price or rating distribution offered. The most recent institutional ratings in the data are from 2016, which are not relevant for current analysis.
Bulls vs Bears: COKE Investment Factors
COKE presents a compelling mix of strong operational performance and concerning financial structure. The company is growing revenue and generating healthy cash flow, but its balance sheet shows significant distortions that complicate valuation. The stock's recent pullback after a strong run adds to the near-term uncertainty.
Bullish
- Strong Revenue Growth: Q4 revenue grew 9.0% YoY, showing solid demand.
- Excellent Operational Efficiency: High ROA of 12.3% indicates efficient asset use.
- Robust Long-Term Price Trend: Stock up 60.7% over 6 months, significantly beating S&P 500.
- Attractive Forward P/E Ratio: Forward P/E of 4.9 suggests low valuation relative to expected earnings.
Bearish
- Concerning Capital Structure: Negative shareholder equity and Debt/Equity of -4.06 raise red flags.
- Recent Price Volatility and Pullback: Stock down 5.3% over the past month, underperforming the market.
- Distorted Return on Equity: ROE of -77.1% is a major anomaly linked to negative equity.
- Limited Analyst Coverage: Only one analyst covered, providing low visibility and consensus.
COKE Technical Analysis
Overall Assessment: The stock has demonstrated a strong long-term uptrend, gaining 60.7% over the past six months and 42.0% over the past year, significantly outperforming the S&P 500. However, recent volatility is evident, with the price pulling back from its 52-week high of $219.65. Short-term Performance: Over the last month, the stock has declined by 5.27%, underperforming the S&P 500's 5.25% drop. In contrast, the three-month performance remains robust with a 25.08% gain, far exceeding the market's 4.63% decline. Current Position: The current price of $191.74 sits approximately 12.7% below its 52-week high and 82.2% above its 52-week low of $105.21, indicating the stock is still in the upper half of its yearly range despite the recent correction.
Beta
0.60
0.60x market volatility
Max Drawdown
-25.4%
Largest decline past year
52-Week Range
$105-$220
Price range past year
Annual Return
+39.2%
Cumulative gain past year
| Period | COKE Return | S&P 500 |
|---|---|---|
| 1m | -4.9% | -4.3% |
| 3m | +29.9% | -4.0% |
| 6m | +61.4% | -2.0% |
| 1y | +39.2% | +22.2% |
| ytd | +29.9% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COKE Fundamental Analysis
Revenue & Profitability: The company shows solid revenue growth, with Q4 2025 revenue of $1.90 billion representing a 9.0% year-over-year increase. Profitability is healthy, with a Q4 net income margin of 7.2% and a trailing twelve-month net margin of 7.9%. Financial Health: The balance sheet shows a current ratio of 1.26, indicating adequate short-term liquidity. However, the debt-to-equity ratio is reported as -4.06, which is an unusual figure often resulting from negative shareholder equity, warranting closer scrutiny of the capital structure. Operational Efficiency: Return on Assets (ROA) is a solid 12.3%, indicating efficient use of assets. In contrast, the Return on Equity (ROE) is reported as -77.1%, which is inconsistent with positive net income and is likely distorted by the negative equity figure.
Quarterly Revenue
$1.9B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$620252000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COKE Overvalued?
Valuation Level: With positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is 19.8, while the forward P/E is significantly lower at 4.9, suggesting expectations of higher future earnings. The Price-to-Sales (P/S) ratio is 1.56. Peer Comparison: Industry average valuation data is not provided in the inputs for a direct comparison. The company's EV/EBITDA of 12.0 and EV/Sales of 2.1 offer additional context for its enterprise value relative to operating performance and sales.
PE
19.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 8x~76x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.0x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk for COKE stems from its unusual capital structure, indicated by a negative debt-to-equity ratio of -4.06 and a negative Price-to-Book ratio. This suggests the company may have significant liabilities or accounting treatments that result in negative shareholder equity, which is atypical for a profitable firm and warrants deep due diligence. Market risk is elevated as the stock has experienced high volatility, with a 25.4% maximum drawdown and a recent 5.3% monthly decline, indicating sensitivity to broader market corrections despite its low beta of 0.57. Furthermore, the lack of recent, substantive analyst coverage (only one analyst) increases information asymmetry and makes it harder for investors to gauge fair value consensus, adding a layer of uncertainty to the investment thesis.